LITS
Lite Strategy, Inc.- Healthcare
- Biotechnology
- $35M market cap
Forecast run · Oct 29, 2026Upside rank 901 of 3,186
Model Signal
ForecastQ Daily Probabilities
36.6%
67.2%
31.1%
Analyst Consensus
RecommendationNot rated
Last price$1.16
Price targetNo target
ForecastQ Portfolios
LITS is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.